Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Depreciation and Depletion (2020 - 2025)

Arcutis Biotherapeutics has reported Depreciation and Depletion over the past 6 years, most recently at $153000.0 for Q1 2025.

  • Quarterly results put Depreciation and Depletion at $153000.0 for Q1 2025, down 10.0% from a year ago — trailing twelve months through Mar 2025 was $623000.0 (down 21.64% YoY), and the annual figure for FY2024 was $640000.0, down 20.0%.
  • Depreciation and Depletion for Q1 2025 was $153000.0 at Arcutis Biotherapeutics, up from $145000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for ARQT hit a ceiling of $227000.0 in Q4 2023 and a floor of $98000.0 in Q1 2021.
  • Median Depreciation and Depletion over the past 5 years was $160000.0 (2022), compared with a mean of $159705.9.
  • Biggest five-year swings in Depreciation and Depletion: surged 420.0% in 2021 and later plummeted 36.12% in 2024.
  • Arcutis Biotherapeutics' Depreciation and Depletion stood at $182000.0 in 2021, then dropped by 12.09% to $160000.0 in 2022, then skyrocketed by 41.88% to $227000.0 in 2023, then tumbled by 36.12% to $145000.0 in 2024, then grew by 5.52% to $153000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $153000.0 (Q1 2025), $145000.0 (Q4 2024), and $161000.0 (Q3 2024) per Business Quant data.